Liu YH - Search Results

1

Extraction of flavonoids from Chrysanthemum morifolium and antitumor activity in vitro.

Liu YH, Mou X, Zhou DY, Zhou DY, Shou CM. Liu YH, et al. Exp Ther Med. 2018 Feb;15(2):1203-1210. doi: 10.3892/etm.2017.5574. Epub 2017 Nov 27. Exp Ther Med. 2018. PMID: 29399116 Free PMC article.

2

Identification of potential therapeutic target genes in mouse mesangial cells associated with diabetic nephropathy using bioinformatics analysis.

Mou X, Zhou DY, Liu YH, Liu K, Zhou D. Mou X, et al. Among authors: liu k, liu yh. Exp Ther Med. 2019 Jun;17(6):4617-4627. doi: 10.3892/etm.2019.7524. Epub 2019 Apr 23. Exp Ther Med. 2019. PMID: 31105790 Free PMC article.

3

[Mechanism of effective components of Mori Folium in alleviating insulin resistance based on JNK signaling pathway].

Liu YH, Mou X, Zhou DY, Shou CM. Liu YH, et al. Zhongguo Zhong Yao Za Zhi. 2019 Mar;44(5):1019-1025. doi: 10.19540/j.cnki.cjcmm.20181213.005. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 30989864 Chinese.

4

Different Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype.

Mou X, Liu Y, Zhou D, Hu Y, Ma G, Shou C, Chen J, Zhou D. Mou X, et al. Iran J Public Health. 2016 Jun;45(6):761-7. Iran J Public Health. 2016. PMID: 27648419 Free PMC article.

5

Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism.

Mou X, Liu WH, Zhou DY, Liu YH, Hu YB, Ma GL, Shou CM, Chen JW, Zhao JX. Mou X, et al. Among authors: liu wh, liu yh. Chin J Integr Med. 2011 Sep;17(9):680-4. doi: 10.1007/s11655-011-0845-5. Epub 2011 Sep 11. Chin J Integr Med. 2011. PMID: 21910069

6

Study on the relationship between Chinese medicine constitutive susceptibility and diversity of syndrome in diabetic nephropathy.

Mou X, Zhou DY, Liu WH, Zhou DY, Liu YH, Hu YB, Shou CM, Chen JW, Zhao JX, Ma GL. Mou X, et al. Among authors: liu wh, liu yh. Chin J Integr Med. 2013 Sep;19(9):656-62. doi: 10.1007/s11655-013-1411-0. Epub 2013 Apr 10. Chin J Integr Med. 2013. PMID: 23576276

7

Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Mou X, Zhou DY, Zhou DY, Ma JR, Liu YH, Chen HP, Hu YB, Shou CM, Chen JW, Liu WH, Ma GL. Mou X, et al. Among authors: liu wh, liu yh. PLoS One. 2016 Feb 22;11(2):e0149513. doi: 10.1371/journal.pone.0149513. eCollection 2016. PLoS One. 2016. PMID: 26901047 Free PMC article. Review.

8

Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy.

Ji L, Chen Y, Wang H, Zhang W, He L, Wu J, Liu Y. Ji L, et al. Int J Oncol. 2019 Jul;55(1):103-115. doi: 10.3892/ijo.2019.4800. Epub 2019 May 14. Int J Oncol. 2019. PMID: 31115579 Free PMC article.

9

Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.

Zhang S, Gao YF, Zhang K, Deng GR, He GX, Gao PP, Yu YK, Yuan Y, Xing SJ, Zhao N, Zhang H, Di-Wu YC, Liu YH, Sui BD, Li Z, Ma J, Zheng CX. Zhang S, et al. Among authors: liu yh. Biochem Biophys Res Commun. 2024 Apr 24;715:149999. doi: 10.1016/j.bbrc.2024.149999. Online ahead of print. Biochem Biophys Res Commun. 2024. PMID: 38678787

10

[The identification of a novel reassortant H3N2 avian influenza virus based on nanopore sequencing technology and genetic characterization].

Cao L, Xia D, Chen YY, Zhou TF, Yin SH, Liu YH, Li KB, Di B, Zhang ZB, Qin PZ. Cao L, et al. Among authors: liu yh. Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Apr 10;45(4):574-578. doi: 10.3760/cma.j.cn112338-20230828-00105. Zhonghua Liu Xing Bing Xue Za Zhi. 2024. PMID: 38678355 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,360 results

Search Page